- Home
- FNWB vs PMVP Comparison
FNWB vs PMVP Comparison
Compare FNWB & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNWB | PMVP |
|---|---|---|
| Founded | 1923 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.9M | 66.0M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FNWB | PMVP |
|---|---|---|
| Price | $9.38 | $1.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $13.50 | $5.00 |
| AVG Volume (30 Days) | 35.2K | ★ 263.3K |
| Earning Date | 01-28-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.49% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $54,052,000.00 | N/A |
| Revenue This Year | $31.86 | N/A |
| Revenue Next Year | $10.64 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $6.05 | $0.81 |
| 52 Week High | $12.10 | $1.84 |
Technical Indicators
Market Signals| Indicator | FNWB | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 35.98 | 49.35 |
| Support Level | $9.88 | $1.21 |
| Resistance Level | $10.08 | $1.27 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 8.07 | 77.78 |
Price Performance
Historical ComparisonAbout FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.